Literature DB >> 17530621

Diagnosing Alzheimer's disease--non-clinicians and computerised algorithms together are as accurate as the best clinical practice.

Catherine M L Foy1, Helen Nicholas, Paul Hollingworth, Harry Boothby, Julie Willams, Richard G Brown, Safa Al-Sarraj, Simon Lovestone.   

Abstract

BACKGROUND: An accurate diagnosis of Alzheimer's disease and an exclusion of other dementias is important in many clinical studies. Obtaining such a clinical diagnosis in epidemiological studies and clinical trials that recruit large numbers of patients is time consuming.
OBJECTIVES: To construct an algorithm using a limited number of data points to generate a diagnosis of the commonest forms of dementia using information collected by non clinicians.
METHODS: We constructed a computer algorithm to generate a diagnosis of Alzheimer's disease (AD), Dementia with Lewy Bodies (DLB), frontotemporal dementia (FTD), vascular dementia or to flag the case as needing a clinical review based on a limited number of data points taken from a largely structured interview using widely used scales. The diagnosis generated in life by the algorithm in a prospective, longitudinal study was compared to definitive diagnosis at post mortem.
RESULTS: Post mortem diagnosis was available for 43 cases. The positive predictive value of the algorithm was greater than 95%. AD was diagnosed by the algorithm and at post mortem in 36 of the cases. Two cases with FTD were wrongly diagnosed as having AD by the algorithm, five cases were flagged as needing a clinical review due to concomitant medical conditions of whom four had AD and one, who had been diagnosed clinically as having AD, was diagnosed on post mortem with corticobasal degeneration.
CONCLUSIONS: A combination of non-clinical researchers, a structured interview and a computerised algorithm is as effective at identifying AD as highly trained and skilled clinicians. Copyright 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2007        PMID: 17530621     DOI: 10.1002/gps.1810

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  9 in total

1.  Biomarkers for Alzheimer's disease trials--biomarkers for what? A discussion paper.

Authors:  S Lovestone; M Thambisetty
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

2.  Differential diagnosis of Alzheimer's disease using spectrochemical analysis of blood.

Authors:  Maria Paraskevaidi; Camilo L M Morais; Kássio M G Lima; Julie S Snowden; Jennifer A Saxon; Anna M T Richardson; Matthew Jones; David M A Mann; David Allsop; Pierre L Martin-Hirsch; Francis L Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-05       Impact factor: 11.205

3.  Blood biomarkers for Alzheimer's disease.

Authors:  Simon Lovestone
Journal:  Genome Med       Date:  2014-08-31       Impact factor: 11.117

Review 4.  A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication.

Authors:  Liu Shi; Alison L Baird; Sarah Westwood; Abdul Hye; Richard Dobson; Madhav Thambisetty; Simon Lovestone
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

5.  Urinary metabolic phenotyping for Alzheimer's disease.

Authors:  Natalja Kurbatova; Manik Garg; Luke Whiley; Elena Chekmeneva; Beatriz Jiménez; María Gómez-Romero; Jake Pearce; Torben Kimhofer; Ellie D'Hondt; Hilkka Soininen; Iwona Kłoszewska; Patrizia Mecocci; Magda Tsolaki; Bruno Vellas; Dag Aarsland; Alejo Nevado-Holgado; Benjamine Liu; Stuart Snowden; Petroula Proitsi; Nicholas J Ashton; Abdul Hye; Cristina Legido-Quigley; Matthew R Lewis; Jeremy K Nicholson; Elaine Holmes; Alvis Brazma; Simon Lovestone
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

Review 6.  Promoting successful participation of people living with Alzheimer's disease and related dementias in pain-related neuroimaging research studies.

Authors:  Wm Larkin Iversen; Todd B Monroe; Sebastian Atalla; Alison R Anderson; Ronald L Cowan; Kathy D Wright; Michelle D Failla; Karen O Moss
Journal:  Front Pain Res (Lausanne)       Date:  2022-08-19

7.  Alzheimer's disease diagnosis by blood plasma molecular fluorescence spectroscopy (EEM).

Authors:  Ricardo Fernandes Dos Santos; Maria Paraskevaidi; David M A Mann; David Allsop; Marfran C D Santos; Camilo L M Morais; Kássio M G Lima
Journal:  Sci Rep       Date:  2022-09-28       Impact factor: 4.996

8.  Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease.

Authors:  Madhav Thambisetty; Andrew Simmons; Latha Velayudhan; Abdul Hye; James Campbell; Yi Zhang; Lars-Olof Wahlund; Eric Westman; Anna Kinsey; Andreas Güntert; Petroula Proitsi; John Powell; Mirsada Causevic; Richard Killick; Katie Lunnon; Steven Lynham; Martin Broadstock; Fahd Choudhry; David R Howlett; Robert J Williams; Sally I Sharp; Cathy Mitchelmore; Catherine Tunnard; Rufina Leung; Catherine Foy; Darragh O'Brien; Gerome Breen; Simon J Furney; Malcolm Ward; Iwona Kloszewska; Patrizia Mecocci; Hilkka Soininen; Magda Tsolaki; Bruno Vellas; Angela Hodges; Declan G M Murphy; Sue Parkins; Jill C Richardson; Susan M Resnick; Luigi Ferrucci; Dean F Wong; Yun Zhou; Sebastian Muehlboeck; Alan Evans; Paul T Francis; Christian Spenger; Simon Lovestone
Journal:  Arch Gen Psychiatry       Date:  2010-07

9.  A genome-wide association study for late-onset Alzheimer's disease using DNA pooling.

Authors:  Richard Abraham; Valentina Moskvina; Rebecca Sims; Paul Hollingworth; Angharad Morgan; Lyudmila Georgieva; Kimberley Dowzell; Sven Cichon; Axel M Hillmer; Michael C O'Donovan; Julie Williams; Michael J Owen; George Kirov
Journal:  BMC Med Genomics       Date:  2008-09-29       Impact factor: 3.063

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.